Fecal Calprotectin Test Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	150 Pages	Coherent Market Insights	June, 2023	CMI18107595

Best Price Guarantee
Price	from $4,500
Length	150 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18107595

Fecal Calprotectin Test Market, By Test Type (Lateral Flow Immunoassay, Enzyme-Linked Immunosorbent Assay (ELISA)), By End User (Hospitals, Diagnostic Laboratories, Clinics and Physician Offices), By Application (Inflammatory Bowel Disease (IBD) Diagnosis, Disease Monitoring, Screening and Early Detection), By Distribution Channel (Direct Sales, Distributors), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Inflammation of the digestive system is brought on by the chronic illness IBD. White blood cells in the intestines release a protein called fecal calprotectin. It is high in IBD patients, making it a helpful biomarker for identifying and tracking the condition.

Market Dynamics:

Increasing prevalence of gastrointestinal disorders, growing awareness and early detection, and non-invasive and convenient testing is anticipated to drive growth of the global fecal calprotectin test market over the forecast period. Moreover, increasing adoption by healthcare providers is also expected to boost growth of the global fecal calprotectin test market over the forecast period. Emerging markets, point-of-care testing, home-based testing kits and integration with digital health technologies options are expected to create growth opportunities for the global fecal calprotectin test market during the forecast period.

However, limited reimbursement coverage, cost considerations, variability in test results and limited awareness and physician knowledge are expected to hamper growth of the global fecal calprotectin test market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global fecal calprotectin test market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fecal calprotectin test market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbexa Limited, Bioserv Diagnostics Gmbh, Epitope Diagnostics, Inc., LifeSpan BioSciences, Inc., RayBiotech, Inc., ALPCO.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global fecal calprotectin test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders have ease in decision-making through various strategy matrices used in analyzing the would global fecal calprotectin test market

Detailed Segmentation:

Global Fecal Calprotectin Test Market, By Test Type:
Lateral Flow Immunoassay
Enzyme-Linked Immunosorbent Assay (ELISA)
Global Fecal Calprotectin Test Market, By End User:
Hospitals
Diagnostic Laboratories
Clinics and Physician Offices
Global Fecal Calprotectin Test Market, By Application:
Inflammatory Bowel Disease (IBD) Diagnosis
Disease Monitoring
Screening and Early Detection
Global Fecal Calprotectin Test Market, By Distribution Channel:
Direct Sales
Distributors
Global Fecal Calprotectin Test Market, By Geography:
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Company Profiles:
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
F.Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Abbexa Limited
Bioserv Diagnostics Gmbh
Epitope Diagnostics, Inc.
LifeSpan BioSciences, Inc.
RayBiotech, Inc.
ALPCO

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Test Type; Market Snapshot, By End User; Market Snapshot, By Application; Market Snapshot, By Distribution Channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing prevalence of gastrointestinal disorders; Rreimbursement coverage for Fecal Calprotectin Tests may be limited; Integration with digital health technologies; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Fecal Calprotectin Test Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Fecal Calprotectin Test Market, By Test Type, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Lateral Flow Immunoassay; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Enzyme-Linked Immunosorbent Assay (ELISA); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Global Fecal Calprotectin Test Market, By End User, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Diagnostic Laboratories; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Clinics and Physician Offices; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
7. Global Fecal Calprotectin Test Market, By Application, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Inflammatory Bowel Disease (IBD) Diagnosis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Disease Monitoring; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Screening and Early Detection; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
8. Global Fecal Calprotectin Test Market, By Distribution Channel, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Direct Sales; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Distributors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
9. Global Fecal Calprotectin Test Market, By Region, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018 –2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)); Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)); Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)); Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn)); Middle East & Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn))
10. Competitive Landscape: Thermo Fisher Scientific Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche Ltd.; Becton, Dickinson and Company; Abbexa Limited; Bioserv Diagnostics Gmbh; Epitope Diagnostics, Inc.; LifeSpan BioSciences, Inc.; RayBiotech, Inc.; ALPCO; Analyst Views
11. Section: Research Methodology; About us; *Browse 24 market data tables and 28 figures on “Global Fecal Calprotectin Test Market” - Global forecast to 2030